Belpointe Asset Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Belpointe Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $8,714 - $14,171	-368 Reduced 54.68%	305 $7,000
Q4 2022 Feb 08, 2023	BUY	$28.0 - $40.56 $18,844 - $27,296	673 New	673 $27,000
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $193,179 - $281,132	-3,309 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$62.15 - $90.32 $15,537 - $22,580	-250 Reduced 7.02%	3,309 $274,000
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $155,955 - $303,831	3,559 New	3,559 $273,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.